Global /China /Healthcare /Drug Manufacturers - General /600812

North China Pharmaceutical Company.Ltd

600812

• SSE: 600812 • Delayed

5.21CNY -1.1%

0.7699 USD

As of 17 June 2026, North China Pharmaceutical Company.Ltd has a market cap of $1.34B USD, ranking #9125 globally and #2434 in China. It ranks #775 in the Healthcare sector, and #294 in the Drug Manufacturers - General industry.

Global Rank

9125

Country Rank

2434

Sector Rank

775

Industry Rank

294

Key Stats

Market Cap

$1.34BUSD

9.04B CNY

Enterprise Value

$3.0BUSD

20.28B CNY

Revenue (TTM)

$1.3BUSD

8.82B CNY

EBITDA (TTM)

$220.68MUSD

1.49B CNY

Net Income (TTM)

$23.78MUSD

161.04M CNY

EBITDA Margin

17%

Profit Margin

1.8%

PE Ratio

56.0

PS Ratio

1.0

PB Ratio

1.3

EV/EBITDA

13.0

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Li Xin Wang open_in_new

Employees

10,000

Founded

1992

Website

ncpc.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.1%	-2.1%	-2.3%	-8.8%	-14%	-5.8%	-14%	-17%	-48%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600812 华北制药股份有限公司 Class A ISIN: CNE000000D16 Shares Out.: Shares Outstanding: 1.631B¹ Shares Float: 1.1B² TV: TradingView: SSE: 600812 SA: Stock Analysis: SHA: 600812 YF: Yahoo Finance: 600812.SS GF: Google Finance: SHA: 600812 BA: Barron's: 600812 MS: Morningstar: XSHG: 600812	5.21 CNY	TV: TradingView: SSE: 600812 SA: Stock Analysis: SHA: 600812 YF: Yahoo Finance: 600812.SS GF: Google Finance: SHA: 600812 BA: Barron's: 600812 MS: Morningstar: XSHG: 600812

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About North China Pharmaceutical Company.Ltd

North China Pharmaceutical Company.Ltd engages in the research and development, production, and sales of pharmaceutical products in China and internationally. The company primarily offers anti-infective drugs, biotechnology drugs, cardiovascular cerebrovascular, immunomodulators, and vitamins and health products. It also provides chemical pharmaceuticals; and biological, agricultural, and veterinary drugs. North China Pharmaceutical Company.Ltd was founded in 1992 and is headquartered in Shijiazhuang, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.89B 364.89B CNY 4K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.67B 336.36B CNY 4K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 2K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 1K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.52B 111.89B CNY 1K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 1K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 57K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 41K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 27K%	97.4	United States
Roche Holding AG SIX: RO	$322.73B 256.25B CHF 24K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.3B 215.59B GBP 22K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$275.68B 218.9B CHF 21K%	20.5	Switzerland

chevron_leftBack